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ABSTRACT
Objective To psychometrically assess the Children and 
Young People- Mental Health Self- harm Assessment in 
Paediatric healthcare Environments (CYP- MH SAPhE) 
instrument for the identification of immediate risk of self- 
harm in CYP, aged 10–19 years, in acute paediatric wards 
or emergency departments.
Design The CYP- MH SAPhE Instrument was developed 
through a robust scoping review and Delphi consensus 
with 30 clinicians/topic experts. To evaluate the 
psychometric properties, a multicentre exploratory study 
was conducted.
Setting Three acute hospitals in the UK.
Participants 163 CYP presenting at acute hospital 
settings with primary mental health (cases) or physical 
health (non- cases) conditions.
Primary and secondary outcome 
measures Psychometric properties of the CYP- MH 
SAPhE instrument were evaluated through Principle 
Axis Factoring (PAF) with Oblimin (Kaiser normalisation) 
alongside measures of internal consistency (Cronbach’s α), 
convergent, discriminant and face validity.
Results PAF of the dichotomous items (n=9) loaded onto 
three factors (1) behaviours and intentions; (2) suicidality 
and (3) self- harm. Factors 1 (Cronbach’s α=0.960) 
and 3 (Cronbach’s α=1) had high internal consistency. 
There was: good level of agreement between raters 
(kappa=0.65); a moderately positive correlation between 
the CYP- MH SAPhE instrument and the Columbia- Suicide 
Severity Rating Scale; and discrimination between 
cases and non- cases across the three factors (factor 1: 
m=88 vs 70; factor 2: m=102 vs 70; factor 3: m=104 
vs 68). Assessment of face validity resulted in six items 
being removed, culminating in an eight question, rapid 
assessment instrument.
Conclusions The results support the CYP- MH SAPhE Tool 
as a potentially reliable and valid instrument to identify 
immediate risk of self- harm in CYP presenting to acute 
paediatric healthcare environments, which is a burgeoning 
and significant global health issue.
INTRODUCTION
Self- harm in children and young people 
(CYP) is becoming increasingly prevalent,1 
with suicide among the most common causes 
of death in young people.2 Consequently, 
self- harm and attempted suicide are common 
reasons for attendance to emergency depart-
ments.3 For the purpose of this study, the 
term self- harm refers to the engagement in 
doing purposeful physical harm to one’s body 
through either injury or poisoning, without 
suicidal intent.4 Importantly, self- harm is 
considered to serve very individual functions, 
for instance, alleviation or distraction from 
strong emotions.4 Attempted suicide is refer-
ring to the purposeful attempt to end one’s 
life and is considered distinctly different to 
self- harm. However, an association has been 
reported between previous self- harm and 
future suicide attempts in young people.5
CYP presenting to emergency departments 
following an attempted suicide or an episode 
of self- harm can require immediate physical 
treatment.6 Following this treatment, there 
are often extended periods of time where 
Strengths and limitations of this study
 ► This is the first publication of a new instrument 
(Children and Young People- Mental Health Self- harm 
Assessment in Paediatric healthcare Environments, 
CYP- MH SAPhE Tool) to rapidly assess (~5 min) sui-
cidality and self- harm of CYP that present to acute 
paediatric settings in mental health crisis.
 ► This instrument has been codeveloped with clini-
cians who deliver front- line care to CYP that present 
to acute paediatric settings in mental health crisis in 
order to maximise its utility.
 ► This instrument will contribute to the awareness, 
understanding and measurement of patient safety 
and guide interventions that may improve outcomes.
 ► Generalisability of the results of this study may be 
limited by the non- probability approach to partici-
pant selection and the homogeneity of the sample.
 ► Further evaluation of the CYP- MH SAPhE instrument 
is required across settings to confirm reliability and 
validity of the instrument.
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CYP are confined to an inpatient environment and cared 
for by paediatric healthcare staff. In cases where imme-
diate physical care is not required, it is not unusual for 
CYP to spend over 5 hours in emergency departments 
before receipt of specialised healthcare or assessment.7 
Typically, healthcare professionals within these environ-
ments have limited mental health training, and as such, 
often feel ill equipped to assess and manage the asso-
ciated risks apparent for CYP presenting following an 
episode of self- harm or attempted suicide.8 Consequently, 
care for self- harm within emergency departments appears 
to be variable, with research showing it be ineffective and 
delayed.9
Although, there have been recent innovations to 
increase the knowledge, skills and confidence in non- 
mental health trained healthcare professionals working 
with CYP within acute paediatric settings,10 there is 
currently no established, evidence- based instrument to 
assess risk. Further, as identified by Carter et al,11 there is 
a paucity of appropriate risk assessment instruments that 
have been psychometrically tested to assess immediate 
risk of self- harm and/or suicide in CYP, thus the current 
lack of recommendation within most current clinical 
guidance is likely appropriate. That being said, consid-
ering the following: (1) there is no evidence of iatrogenic 
effects from assessing for risk of self- harm or suicide in 
CYP;12 (2) there is a paucity of mental health training for 
emergency department and acute paediatric inpatient 
workforce and (3) many CYP admitted to acute hospital 
settings following self- harm or attempted suicide may 
present as immediate risk to themselves, the need for a 
valid and reliable instrument for use by paediatric health 
professionals appears high.
The aim of this study was to develop and undertake an 
exploratory evaluation of the psychometric properties of 
an instrument assessing immediate risk of suicide and 




Initially, a scoping review was undertaken by the study 
team11 whereby 14 assessments of self- harm and/or 
suicide risk in CYP that the team were able to access, and 
that had been subject to some form of reliability and/
or validity testing were included. These included: Adoles-
cent Suicide Questionnaire;13 Child suicide potential 
scale;14 Columbia Suicide Screen;15 Columbia Suicide 
Severity Rating Scale (C- SSRS);16 Multi- Attitude Suicide 
Tendency scale;17 Reasons for living inventory for adoles-
cents;18 Risk of Suicide Questionnaire;19 Modified Scale 
for Suicide Ideation;20 Suicidal Behaviours Question-
naire for Children;21 Suicidal Ideation Questionnaire;22 
Suicidal ideation questionnaire- junior;23 Suicide Intent 
Scale;24 Suicide Probability Scale25 and Fairy Tales Test.26 
The individual items from each of the 14 instruments 
were extracted and reviewed via a Delphi process by 30 
experts from clinical practice and academia. Following 
three Delphi rounds, consensus was gained on 10 suicide 
risk items.
A nominal group technique (NGT) meeting was then 
undertaken with six field experts from clinical prac-
tice. Face validity was agreed with nine self- harm items 
included from Delphi rounds 2 and 3. Through the 
NGT process, 5 out of the 19 items were removed (three 
were duplicates and two would likely have been assessed 
through routine physical care treatment). The final 
14- items achieved unanimous agreement from the six 
participants for phrasing, ordering and scaling (figure 1).
Sample and procedures
A multicentre cohort study was conducted to examine the 
validity and reliability of the developed instrument (the 
CYP- Mental Health Self- harm Assessment in Paediatric 
healthcare Environments CYP- MH SAPhE) in CYP (aged 
10–19 years) admitted to acute paediatric healthcare 
settings. Study sites were located in England and included 
(1) two Children’s Hospitals located within large tertiary 
university teaching hospitals and (2) a children’s service 
at an acute general district hospital. A detailed account of 
methods and procedure has been previously outlined by 
Manning et al.27
Figure 1 A14- item CYP- MH SAPhE Instrument. CYP- MH 
SAPhE, Children and Young People- Mental Health Self- harm 
Assessment in Paediatric healthcare Environments.
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A purposive sample of CYP were recruited from emer-
gency departments and paediatric inpatient wards at 
three acute hospitals between October 2017 and April 
2018. Participants were selected using a pre- determined 
eligibility criteria outlined in table 1.
Recruitment was performed by registered clinical staff 
and research nurses. Following an informed consent 
procedure, data were collected by registered clinical staff. 
Demographics and presenting information (date of birth; 
gender; ethnicity; recruitment site, hospital number; 
primary reason for presentation to hospital (International 
Classification of Diseases (ICD)-10 categories); previous 
hospital presentations for mental health crisis (within 
last 6 months); and treating physician contact details, 
were collected from all participants. The CYP- MH SAPhE 
instrument and the C- SSRS were administered to partic-
ipants defined as ‘cases’. ‘Non- cases’ only completed the 
CYP- MH SAPhE instrument. Data were entered into a 
secure, password protected, study management database 
and checked prior to conduct of any analyses.
Sample size calculations indicated 4–10 participants per 
scale item, with a minimum of 100 subjects.28 The draft 
instrument included 14 scale items. Therefore, we aimed 
to recruit between 100 (as this is the minimum number) 
to 140 CYP in total (50–70 cases and 50–70 non- xases).
Additional measures
The C- SSRS is a clinician rated, 19- item, measure of 
suicide risk.29 Considered the current gold- standard 
assessment for suicide risk, the C- SSRS has good predic-
tive validity, discriminant validity, convergent validity, and 
sensitivity and specificity.29 The C- SSRS was completed 
with ‘cases’ only to enable assessment of the level of agree-
ment (convergent validity) with the CYP- MH SAPhE. This 
was because it was deemed inappropriate to ask non- 
clinical cases the questions subsumed within the C- SSRS 
on hospital admission due to their sensitive nature.
Data analysis
Data were analysed using the latest available version of 
IBM SPSS V.24. Counts and percentages were calculated 
for dichotomous and categorical variables and descriptive 
statistics for continuous variables. Analysis was conducted 
to establish any differences between groups (cases and 
non- cases) and sample characteristics of age, sex and 
setting using independent t- test (age) or McNemars Test 
(sex and setting). The Mann- Whitney U test was used 
to establish differences between cases and non- cases for 
CYP- MH SAPhE instrument dichotomous item responses. 
Values of 95% CIs were calculated and where appropriate, 
statistical significance was reported with the threshold of 
0.05.
All participants were included in the final analysis with 
any missing data handled using list wise deletion as impu-
tation was not suitable for C- SSRS.
A standard psychometric approach was taken to explore 
the psychometric properties of the CYP- MH SAPhE 
instrument. The Factor structure was analysed using Prin-
cipal Axis Factoring (PAF) with Oblimin (Kaiser Normal-
isation). The 14- item instrument included both Likert 
and dichotomous item responses, some of the items were 
contingent on the answers to other items, and one was 
qualitative. As such the instrument as a whole did not lend 
itself to meaningful Factor analysis and the dichotomous 
and Likert scale items were explored separately. Internal 
consistency was analysed using Cronbach’s α. Congruent 
validity was determined via Spearman’s r correlation for 
non- parametric data. Discriminant validity was explored 
via Mann- Whitney U test. Finally face validity was estab-
lished through expert panel review, which was composed 
of expert clinicians and academics.
Patient and public involvement
The inception and design of this study was informed 
through meaningful engagement with patient, public and 
expert professionals. CYP, their parents and carers, and 
professionals from both acute paediatric care and child 
and adolescent mental health services have informed the 
topic and focus of the study through previous stakeholder 
engagement led by JCM and funded by National Health 
Service (NHS) England. In the development of this study, 
we have involved CYP to inform the focus, design and 
development of study information such as the participant 
information sheets. In addition, a group of clinical and 
research experts were assembled to steer the direction of 
this study. This included staff members who provide care 
for CYP experiencing mental health problems and crisis 
Table 1 Eligibility criteria
Inclusion criteria Exclusion criteria
1. Aged 10–19 years.
2. ‘Cases’ who presented to acute paediatric hospital setting in mental 
health crisis(defined as: having reached ‘breaking point’, likely to harm 
themselves or others and behaviours that feel out of control, including 
extreme anxiety or panic attacks; psychotic episodes; hypomania or mania 
and acts of suicide or self- harm).
3. ‘Non- cases’ presenting to acute paediatric setting not in mental health 
crisis but with a primary physical medical illness or injury(defined as 
a health problem having physical origins, which can be short- term 
(accidental injury, influenza, migraine, infections) or long term (eg, diabetes, 
asthma, arthritis)).
1. Unable to speak or comprehend English 
language.
2. Currently receiving active end of life care.
3. Considered too medically ill by clinicians.
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events on a daily basis in a range of settings that include 
NHS, Local Government and charity organisations.
RESULTS
Participants
In total, 163 CYP met the eligibility criteria and were 
recruited into the study. The sample characteristics are 
summarised in table 2.
The mean age of the total sample was 14.3 years (SD 
1.8), with most of the participants being female (66.3%), 
and of white British/Irish ethnicity (87.1%). Approxi-
mately half of the sample were located within an inpatient 
ward setting at the time of data collection (57.7%). Most 
of the sample had not experienced a previous episode of 
mental health crisis that warranted admission to inpatient 
care or attendance to ED (84%). The sample consisted 
of 62 ‘cases’ and 101 ’non- cases’, with analysis showing 
no statistically significance differences between groups in 
relation to age (t=1.439; mean difference .422; 95% CI 
−0.157 to 1.002), sex (Asymp. p=0.396) or setting (Asymp. 
p=0.483).
Overview of instrument responses
A summary of participant responses to the CYP- MH 
SAPhE instrument and the C- SSRS are presented in the 
tables 3–5). Specifically, table 3 presents responses to the 
dichotomous items and table 3 compares the responses 
to the Likert items of the CYP- MH SAPhE instrument for 
both cases and non- cases. Table 5 presents counts and 
percentages for Suicidal Ideation, Suicidal Behaviour and 
Self Injurious Behaviour without Suicidal Intent Based on 
the C- SSRS items from cases only.
Factor analysis
Analysis of Likert Items for self-harm and Suicide
The four Likert scale items included in the instrument 
were narrated as two Factors, one being self- harm and 
one suicidality. We wanted to determine that these were 
indeed two discrete Factors with a view to identifying 
self- harm and suicidality as two separate risk assessments 
that form together a battery of assessment. We therefore 
explored the suitability of these items for Factor analysis. 
A total score was computed as the sum of ratings across all 
four Likert scale items. Individual items were correlated 
with the sum total of the scale and were excluded where 
r<0.3.30 No items were excluded from further analysis 
leaving the four items for inclusion in the Factor anal-
ysis. PAF with Oblimin (Kaiser normalisation) rotation 
was conducted on the four items. The Kaiser- Meyer Olkin 
(KMO) measure of sampling adequacy suggested that 
the sample was not Factorable (KMO=0.584). Although 
Bartlett’s Test of Sphericity was highly significant (χ2=505, 
df=6, p<0.001), high off- diagonal values in the anti- image 
correlation matrix suggested that the data were not suit-
able for factor analysis.31
Analysis of dichotomous items for self-harm and suicide
The nine dichotomous scale items included in the 
instrument were explored for their suitability for Factor 
analysis. A total score was computed as the sum of ratings 
across all nine dichotomous items. Individual items were 
correlated with the sum total of the scale. Point biserial 
correlations were excluded where r<0.3.32 As a result no 
items were excluded from further analysis.
PAF with Oblimin (Kaiser normalisation) rotation 
was conducted on the nine items. The KMO measure of 








Age (years); mean 
(SD)
14.6 (1.7) 14.2 (1.9) 14.3 (1.8)
Gender; n (%)
  Male 13 (21.3) 41 (39.2) 54 (32.5)
  Female 49 (78.7) 59 (59.8) 108 (66.3)
  MD – 1 (1) 1 (1.2)
Ethnicity; n (%)
  African – 3 (2.9) 3 (1.8)
  British/African – 1 (1.0) 1 (0.6)
  British/Pakistani 1 (1.6) – 1 (0.6)
  Chinese – 2 (2.0) 2 (1.2)
  Indian 1 (1.6) 1 (1.0) 2 (1.2)
  Middle- Eastern 1 (1.6) – 1 (0.6)
  Mixed Race 2 (3.3) 2 (2.0) 4 (2.5)
  Pakistani – 3 (2.9) 3 (1.8)
  White British/Irish 57 (91.8) 86 (84.3) 142 (87.1)
  Other – 3 (2.9) 3 (1.8)
  MD – 1 (1.0) 1 (0.6)
Setting; n (%)
  Inpatient ward 33 (54.1) 62 (60.1) 94 (57.7)
  Emergency 
department
29 (45.9) 40 (39.9) 69 (42.3)
Previous mental 
health crisis;* n (%)
  Yes 19 (31.1) 1 (2.0) 20 (12.3)
  No 42 (67.2) 95 (94.1) 137 (84)
  MD 1 (1.7) 4 (3.9) 1 (0.6)
Primary 
presentation;† n (%)
  Suicide attempt 37 (60.6) – –
  Suicidal thoughts 4 (6.6)
  Self- harm 
behaviour
9 (14.7)
  Depression/low 
mood
4 (6.6)
  Eating disorder 5 (8.2)
  Substance misuse 2 (3.3)
*Previous 6- month period.
†Mental health crisis data presented for cases only.
MD, missing data.
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sampling adequacy suggested that the sample was Factor-
able (KMO=0.719). Bartlett’s test of sphericity was highly 
significant (χ2=5352, df=36, p<0.001), low off- diagonal 
values in the anti- image correlation matrix suggested that 
the data were suitable for factor analysis.31 Observation 
of the scree plot indicated a parsimonious three factorial 
structure explaining 93% of total variance.
The pattern matrix was used for interpretation (table 6). 
No items were excluded as they all met the Comrey and 
Lee33 ‘fair’ threshold for Factor loading criterion on 0.45 
and no cross- loadings were observed. Based on these 
criteria, five items loaded on to factor 1. These items 
related to behaviours and intentions. Two items loaded 
on to factor 2. These items were related to suicidality and 
two items loaded onto factor 3. These items related to 
self- harm.
Reliability
Items in factor 1 demonstrated high reliability (Cron-
bach’s α=0.960), items in factor 2 demonstrated poor 
reliability (Cronbach’s α=0.456) and items in factor 3 
demonstrated high reliability (Cronbach’s α=1). Inter- 
rater analysis demonstrated a significantly significant and 
good level of agreement between raters (kappa=0.65, 
p<0.001).
Congruent validity
We hypothesised that the CYP- MH SAPhE instrument 
would positively correlate with The C- SSRS. We found 
a statistically significant (two tailed) moderate posi-
tive correlation between the two instruments (rs=0.438, 
p=0.001). The CYP- MH SAPhE instrument seeks to 
measure risk of both self- harm and suicide whist the 
C- SSRS is a measure of suicidal ideation and behaviour 
only. This moderate correlation would suggest that the 
CYP- MH SAPhE instrument is correlating on the suicidal 
ideation and behavioural aspects of the C- SSRS but is also 
capturing another dimension (self- harm) and therefore 
diverges with the C- SSRS as well.
Discriminant/divergent validity
We hypothesised that there would be a significant differ-
ence between the mean scores of cases presenting with 
MH crisis and non- cases, presenting at services not in MH 
crisis. Mann- Whitney U test indicated that the mean score 
for the Likert scale items was significantly greater in cases 
(m=88) than in non- cases (m=70), U=2416, p=0.020.
Factor 1: Mann- Whitney U test indicated that the 
mean score for Factor 1 was significantly greater in cases 
(m=102) than in non- cases (m=70), U=1882, p<0.001. 
Factor 2: Mann- Whitney U test indicated that there was 
a small but significant differences between mean scores 
of cases (m=86) and non- cases (m=74), U=2649, p=0.048. 
Factor 3: Mann- Whitney U test indicated that the mean 
score for factor 3 was significantly greater in cases of crisis 
(m=104) than in non- cases (m=68), U=1739, p<0.001.
Face validity
Evaluation of the application of the instrument led to 
questions 3, 4, 5a and 9 being removed from, and a ‘don’t 
know’ box being added to question 7. The remaining 
questions 5 and 6 that ended with the terminology ‘end 
your life/kill yourself’ were restricted to just an ‘end your 
life’. The instrument was also colour coded for scoring 
purposes using a green- red flagging system. The expert 
Table 3 Summary of dichotomous item responses from cases and non- cases to the CYP- MH SAPhE instrument
Dichotomous item
Cases (N=62)
Count (% of group)
Non- cases (N=101)
Count (% of group)
Yes No MD Yes No MD
1. At the moment, do you have any thoughts to harm 
yourself?
30 (48.4) 32 (51.6) 0 (0) 0 (0) 101 (100) 0 (0)
2. Do you have anything with you that you plan to use to 
hurt yourself with?
3 (4.8) 59 (95.2) 0 (0) 0 (0) 101 (100) 0 (0)
3. Since being in hospital, have you taken any alcohol 
and/or substances (such as drugs, solvents, prescribed 
and non- prescribed medications)?
1 (1.6) 61 (98.4) 0 (0) 6 (5.9) 95 (94.1) 0 (0)
5. At the moment, are you having any thoughts about 
ending your life/ killing yourself?
29 (46.8) 33 (53.2) 0 (0) 0 (0) 101 (100) 0 (0)
6. Do you intend to end your life/kill yourself? 19 (30.6) 37 (59.7) 6 (9.7) 1 (1.0) 100 (99.0) 0 (0)
7. Right now, do you wish you were dead? 26 (41.9) 36 (58.1) 0 (0) 0 (0) 101 (100) 0 (0)
8. At the moment, do you have a plan to end your life? 13 (21.0) 49 (79.0) 0 (0) 0 (0) 101 (100) 0 (0)
8a. While you are here, have you made any preparations 
to carry out this plan?
0 (0) 62 (100) 0 (0) 0 (0) 101 (100) 0 (0)
8b. While you are here, do you expect to die from this 
plan?
3 (4.8) 59 (95.2) 0 (0) 0 (0) 101 (100) 0 (0)
CYP- MH SAPhE, Children and Young People- Mental Health Self- harm Assessment in Paediatric healthcare Environments; MD, missing data.









pen: first published as 10.1136/bm





6 Manning JC, et al. BMJ Open 2021;11:e043762. doi:10.1136/bmjopen-2020-043762
Open access 
panel subsequently reviewed and agreed these changes 
that culminated in the final instrument (figure 2).
DISCUSSION
Prior to this study, there was no established, psychomet-
rically tested instrument to assess immediate risk of self- 
harm and suicide in CYP presenting to acute paediatric 
healthcare within emergency departments and inpatient 
settings. Thus, limiting the ability of non- mental health 
trained staff working in these areas to effectively and 
systematically assess risk and support safety management 
decisions for CYP presenting in mental health crisis.
Through a thorough scope of the existing literature34 
and subsequent collaboration with an expert panel of 
academics and clinicians, an instrument was developed 
to assess immediate risk of suicide and/or self- harm in 
CYP presenting in mental health crisis to acute paediatric 
hospital settings and emergency departments.
Testing of the instrument across three acute hospital 
sites (Paediatric Emergency Departments and Acute 
Paediatric Wards) within the UK resulted in an eight- item 
instrument, weighted into two constructs (self- harm and 
suicidality) being developed. The results demonstrate 
that the CYP- MH SAPhE instrument is reliable, with high 
levels of internal consistency across the two constructs 
and high levels of inter- rater reliability. The instrument 









































































































































































































































































































































































































































































































































































































































































































































Table 5 Number of cases with suicidal ideation, suicidal 
behaviour and self injurious behaviour without suicidal intent 
based on the C- SSRS items




Suicidal Ideation (at least one ‘yes’ 
response to items)
53 (85.5)
Wish to be dead 49 (79.0)
Non- specific active suicidal thoughts 48 (77.4)
Active suicidal ideation with any methods 
(not plan) without intent to act
39 (62.9)
Active suicidal ideation with some intent 
to act, without specific plan
38 (61.3)
Active suicidal ideation with specific plan 
and intent
21 (33.9)
Suicidal behaviour (at least one ‘yes’ 
response to items)
56 (90.3)
Actual attempt (non- fatal) 48 (77.4)
Interrupted attempt 35 (56.5)
Aborted or self- interrupted attempt 29 (46.8)
Preparatory acts or behaviour 43 (69.4)
Suicidal behaviour 14 (22.6)
Engaged in non- suicidal self- injurious 
behaviour
45 (72.6)
C- SSRS, Columbia- Suicide Severity Rating Scale.
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previously developed in- depth instrument designed to 
assess suicide risk, and high levels of discriminant validity 
suggesting it is able to adequately discriminate between 
CYP presenting with a primary mental health crisis and 
those CYP presenting to acute paediatric setting with a 
primary physical medical illness or injury. The instrument 
was also face valid in that it was acceptable and under-
standable to CYP evident from the minimal amount of 
missing data.
This study has several limitations that must be noted. 
First, the Likert scale data were not suitable for factor 
analysis. There are several reasons why this may be the 
case, for example, with a more robust sample size sample 
adequacy may have been reached. However, the instru-
ment as it stands was derived using both a top down and 
bottom up process that through the Delphi method, 
developed iteratively into self- harm and suicide facets. 
Considering the robustness of our development process 
and the extant literature that would define self- harm and 
suicide as separate constructs, this appears appropriate. 
Future exploration of factor 2 ‘Suicidality’ is required 
to determine the robustness of this Factor as within this 
current sample it demonstrated poor reliability. It may be 
that the ‘planning’ aspects of suicidality are not as suit-
able to Factor analysis as they represent events that are yet 
to come or, it may be that within our sample, not enough 
participants were in this planning state for us to accurately 
explore this Factor. Moreover, it should be acknowledged 
that while the psychometric item evaluation allows us to 
better understand the relationships between variables, 
the strength of the scale lies in its codevelopment by those 
in clinical practice for application within a clinical prac-
tice setting. Second, generalisability of the results of this 
study may be limited by the non- probability approach to 
participant selection and the homogeneity of the sample 
which included predominantly female CYP, with white 
British ethnicity. Third, it should be noted that in some 
instances inter- rater assessments were made up to 4 hours 
apart. This may have influenced agreement as this time 




and intentions 2: Suicidality 3: Self- harm
Q5. At the moment, are you having any thoughts about ending your 
life/ killing yourself?
0.993
Q3. Since being in hospital, have you taken any alcohol and/or 
substances (such as drugs, solvents, prescribed and non- prescribed 
medications)?
0.993
Q8. At the moment, do you have a plan to end your life? 0.954
Q7. Right now, do you wish you were dead? 0.932
Q6. Do you intend to end your life/kill yourself? 0.722
Q8b. While you are here, do you expect to die from this plan? 0.992
Q8a. While you are here, have you made any preparations to carry 
out this plan?
0.991
Q1. At the moment, do you have any thoughts to harm yourself? 0.999
Q2. Do you have anything with you that you plan to use to hurt 
yourself with?
0.999
*It is important to note that Factor analysis of dichotomous variables may lead to the endorsement of strong items rather than picking up on 
underlying latent variables so should be taken as guidance only and with caution.
Figure 2 Final CYP- MH SAPhE Instrument .27 CYP- MH 
SAPhE, Children and Young People- Mental Health Self- harm 
Assessment in Paediatric healthcare Environments.
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Open access 
lapse in the assessment may well see notable changes in 
clinical presentation. Fourth, non- cases did not complete 
the C- SSRS. Therefore, we are unable to establish conver-
gent validity with the CYP- MH SAPhE instrument in those 
with a non- mental health- related primary presentation. 
Collectively, these limitations need to be comprehended 
and mitigated in future evaluative work relating to the 
CYP- MH SAPhE instrument.
Despite these recognised limitations, this study has 
revealed that the CYP- MH SAPhE instrument is a rapid 
and sensitive instrument to identify immediate risk of 
self- harm and suicidality in CYP (aged 10–19 years) 
presenting to acute paediatric care. The CYP- MH SAPhE 
Tool has potential utility as a screener by the paediatric 
health professional in the inpatient ward or emergency 
department as part of their holistic assessment of the 
CYP. Due to the increasing global prevalence of young 
people presenting to acute paediatric settings in acute 
mental health crisis, the CYP- MH SAPhE instrument now 
requires further evaluation to confirm its suitability and 
effectiveness in clinical practice.
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